Pay in 4 interest-free payments of $6.88 Learn more
Ships within 48 hours · Estimated delivery Oct 6 - Oct 11
Join Communities APhA ENGAGE Download the APhA ENGAGE app today The APhA ENGAGE app makes it easier to stay connected, join conversations, and engage with your community on the go
In a 1992 study in rats, the major finding was that intraperitoneal DSIP injection increased the concentration of substance P a neurotransmitter positively correlated with the regulation of anxiety and mood15 in the hypothalamus, suggesting to the researchers that the peptide sharply decreases the classical manifestations of stress.16 Earlier studies in humans, namely a series of five trials published in 1983, came to similar conclusions, with better relaxation and apparently improved tolerance against psychic stress reported by the subjects.17 Its possible that the improved stress and anxiety markers were consequent to DSIP-associated sleep enhancements.18 Substance use recovery A study from 1984 published in European Neurology describes DSIPs potential use as a treatment for alcohol and opiate use disorders
Ikeno, G.B
Kidney disease is the term for the gradual loss of kidney function over time
Punctured vials during travel: Vials in active multi-dose use require the same storage discipline during travel as at home: temperature control, light protection, and aseptic technique on every draw
